EMERGING TESTS

Invitae Greatly Expands Testing Panels, Introduces Pricing for Uninsured

San Francisco-based startup laboratory Invitae has dramatically expanded its menu of test offerings and is also offering significant discounts to uninsured patients. The company said it was providing … [Read more...]

EMERGING TESTS

FDA Intervenes on Development of New Zika Test

The health care sector may have developed a rapid detection diagnostic test for the Zika virus, but the U.S. Food and Drug Administration (FDA) may wind up intervening prior to it making a significant … [Read more...]

EMERGING TESTS

Patient Age Can Impact Gene Expression

A new study commissioned by the Provista Diagnostics molecular laboratory has concluded that the age of patients can play a role in the expression of genes. Specifically, the study addressed … [Read more...]

EMERGING TESTS

VolitionRx Uses Nucleosome Technology for Early Cancer Diagnosis

Cameron Reynolds CEO, VolitionRx Jake Micallef, Ph.D., CSO, VolitionRx VolitionRx (Belgium) is tackling cancer diagnostics 160 base pairs (BP) at a time. The company’s nucleosome- … [Read more...]

EMERGING TESTS

Methylation Patterns Are New Target for ctDNA Analysis

Tests that measure circulating DNA are not entirely new. Yet, until now such tests have been unable to determine the tissue of origin (other than in cases of noninvasive prenatal testing, in which DNA … [Read more...]

EMERGING TESTS

FDA Approves Great Basin Scientific Test for Quick Staph Identification

By Ron Shinkman, Editor, Laboratory Industry Report Salt Lake City-based Great Basin Scientific has said it has received clearance from the U.S. Food and Drug Administration for a test that provides … [Read more...]

EMERGING TESTS

Inflammatory Markers May Diagnose Back Conditions

Biochemical profiles of blood may improve diagnosis of conditions contributing to low back pain (LBP), according to a study published online Jan. 7 in Arthritis Research & Therapy. LBP is … [Read more...]

EMERGING TESTS

NGS-Based Test for CF Promises Faster, Cheaper, More Thorough Analysis

Testing for the cystic fibrosis (CF) helped to fuel the first wave of clinical molecular diagnostics. Now, an assay developed by researchers at the Stanford University taps the power of multiplex … [Read more...]

EMERGING TESTS

Transgenomic Announces Two New Tests for Colorectal Cancer, Melanoma

By Ron Shinkman, Editor, Laboratory Industry Report Transgenomic has released two new liquid biopsy tests for colorectal cancer and metastatic melanoma. Both panels will focus on genetic mutations … [Read more...]

TECHNOLOGY

Neoteryx–A Less Ambitious Version of Theranos?

A California startup has launched a platform that can gather blood in tiny tubes for assays with all but no inconvenience for patients. And it is not Theranos. Unlike that troubled Silicon Valley … [Read more...]


(-00000g2)